Therapeutic targets of renin-angiotensin system in ocular disorders

Fyhrquist, 2008, Renin-angiotensin system revisited, J Intern Med, 264, 224, 10.1111/j.1365-2796.2008.01981.x White, 2015, Expression of classical components of the renin-angiotensin system in the human eye, J Renin Angiotensin Aldosterone Syst, 16, 59, 10.1177/1470320314549791 Cheng, 2005, Angiotensin II and vascular inflammation, Med Sci Monit, 11, RA194 Culman, 1995, Angiotensin as neuromodulator/neurotransmitter in central control of body fluid and electrolyte homeostasis, Clin Exp Hypertens, 17, 281, 10.3109/10641969509087071 Qi, 2014, Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy, Endocrinology, 155, 2254, 10.1210/en.2013-2011 Chung, 1998, Physiological and pharmacological implications of AT1 versus AT2 receptors, Kidney Int, 67, S95, 10.1046/j.1523-1755.1998.06719.x Cao, 2000, Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis, Kidney Int, 58, 2437, 10.1046/j.1523-1755.2000.00427.x Levy, 1996, Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure, J Clin Invest, 98, 418, 10.1172/JCI118807 Sarlos, 2003, Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin, Am J Pathol, 163, 879, 10.1016/S0002-9440(10)63448-7 Rong, 2001, Control of renin secretion from adrenal gland in transgenic Ren-2 and normal rats, Mol Cel Endocrinol, 173, 203, 10.1016/S0303-7207(00)00406-8 Wilkinson-Berka, 2002, Characterization of a thymic renin-angiotensin system in the transgenic m(Ren-2)27 rat, Mol Cel Endocrinol, 194, 201, 10.1016/S0303-7207(02)00217-4 Kurihara, 2012, Renin angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction, Int J Inflam, 581695, 14 Danser, 1989, Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy, J Clin Endocrinol Metab, 68, 160, 10.1210/jcem-68-1-160 Sramek, 1988, Ocular renin-angiotensin: immunohistochemical evidence for the presence of prorenin in eye tissue, Invest Ophthalmol Vis Sci, 29, 1749 Wallow, 1993, Ocular rennin angiotensin: immunocytochemical localization of prorenin, Curr Eye Res, 12, 945, 10.3109/02713689309020401 Berka, 1995, Renin-containing Muller cells of the retina display endocrine features, Invest Ophthalmol Vis Sci, 36, 1450 Brandt, 1994, Renin mRNA is synthesized locally in rat ocular tissues, Curr Eye Res, 13, 755, 10.3109/02713689409047011 Milenkovic, 2010, Regulation of the renin expression in the retinal pigment epithelium by systemic stimuli, Am J Physiol Ren Physiol, 299, F396, 10.1152/ajprenal.00576.2009 Ramirez, 1996, J Ocul Pharmacol Ther, 12, 299, 10.1089/jop.1996.12.299 Wagner, 1996, Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system, Br J Ophthalmol, 80, 159, 10.1136/bjo.80.2.159 Danser, 1994, Angiotensin levels in the eye, Invest Ophthalmol Vis Sci, 35, 1008 Goel, 1991, Vitreous level of angiotensin-II in patients with diabetic retinopathy, Invest Ophthalmol Vis Sci, 32, 1027 Savaskan, 2004, Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and angiotensin AT1 receptor in human ocular tissues, Ophthalmic Res, 36, 312, 10.1159/000081633 Senanayake, 2007, Angiotensin II and its receptor subtypes in the human retina, Invest Ophthalmol Vis Sci, 48, 3301, 10.1167/iovs.06-1024 Holappa, 2015, Angiotensin(1–7) and ACE2, “The hot spots” of renin-angiotensin system, detected in the human aqueous humor, Open Ophthalmol J, 9, 28, 10.2174/1874364101509010028 Ferrari, 1988, Angiotensin-converting enzyme in bovine, feline, and human ocular tissues, Invest Ophthalmol Vis Sci, 29, 876 Geng, 2003, Angiotensin converting enzyme (ACE) activity in porcine ocular tissue: effects of diet and ACE inhibitors, J Pharm Ther, 19, 589 Igic, 1980, Angiotensin I converting enzyme (kininase II) in ocular tissues, Exp Eye Res, 30, 299, 10.1016/0014-4835(80)90010-X Ikemoto, 1978, Renin angiotensin system in the aqueous humor of rabbits, dogs and monkeys, Exp Eye Res, 27, 723, 10.1016/0014-4835(78)90042-8 Immonen, 1987, Concentration of angiotensin-converting enzyme in tears of patients with sarcoidosis, Acta Ophthalmol Copenh, 65, 27, 10.1111/j.1755-3768.1987.tb08486.x Kida, 2003, Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human Muller cells, J Ophthalmol, 47, 36 Maruichi, 2004, Measurement of activities in two different angiotensin II generating systems, chymase and angiotensin-converting enzyme, in the vitreous fluid of vitreoretinal diseases: a possible involvement of chymase in the pathogenesis of macular hole patients, Curr Eye Res, 29, 321, 10.1080/02713680490516161 Sharma, 1983, Determination of angiotensin converting enzyme in tears: a noninvasive test for evaluation of ocular sarcoidosis, Arch Ophthalmol, 101, 559, 10.1001/archopht.1983.01040010559004 Shiota, 1997, Angiotensin II generating system in dog and monkey ocular tissues, Clin Exp Pharmacol Physiol, 24, 243, 10.1111/j.1440-1681.1997.tb01814.x Strittmatter, 1989, Localisation of angiotensin converting enzyme in the ciliary epithelium of the rat eye, Invest Ophthalmol Vis Sci, 30, 2209 Vita, 1981, Angiotensin converting enzyme activity in ocular fluids, Invest Ophthalmol Vis Sci, 20, 255 Ward, 1979, Angiotensin I converting enzyme (kininase II) in isolated retinal microvessels, Life Sci, 24, 1419, 10.1016/0024-3205(79)90013-4 Weinreb, 1985, Angiotensin converting enzyme activity in human aqueous humor, Arch Ophthalmol, 103, 34, 10.1001/archopht.1985.01050010038013 Zhang, 2003, Captopril inhibits glucose accumulation in retinal cells in diabetes, Invest Ophthalmol Vis Sci, 44, 4001, 10.1167/iovs.02-1193 Luhtala, 2009, Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues, J Ocul Pharmacol Ther, 25, 23, 10.1089/jop.2008.0081 Tikellis, 2004, Identification of angiotensin converting enzyme 2 in the rodent retina, Curr Eye Res, 29, 419, 10.1080/02713680490517944 Satofuka, 2006, Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin, Invest Ophthalmol Vis Sci, 47, 2686, 10.1167/iovs.05-1458 Wilkinson-Berka, 2010, Prorenin and the (pro) renin receptor: do they have a pathogenic role in the retina?, Front Biosci Elite Ed, 2, 1054, 10.2741/e163 Buschini, 2015, Recent developments in the management of dry age-related macular degeneration, Clin Ophthalmol, 9, 563, 10.2147/OPTH.S59724 Downie, 2009, Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina, Neuroscience, 161, 195, 10.1016/j.neuroscience.2009.02.084 Fletcher, 2010, The renin-angiotensin system in retinal health and disease: its influence on neurons, glia and the vasculature, Prog Retin Eye Res, 29, 284, 10.1016/j.preteyeres.2010.03.003 Murata, 1997, Expression and localization of angiotensin II type I receptor mRNA in rat ocular tissues, Ophthalmologica, 211, 384, 10.1159/000310835 Wheeler-Schilling, 1999, Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat, Euro J Neurosci, 11, 3387, 10.1046/j.1460-9568.1999.00787.x Vaajanen, 2008, Angiotensin (1–7) reduces intraocular pressure in the normotensive rabbit eye, Invest Ophthalmol Vis Sci, 49, 2557, 10.1167/iovs.07-1399 Vaajanen, 2010, Angiotensin receptors in the eyes of arterial hypertensive rats, Acta Ophthalmol, 88, 431, 10.1111/j.1755-3768.2009.01563.x Vaajanen, 2015, The expression of Mas-receptor of the renin–angiotensin system in the human eye, Graefes Arch Clin Exp Ophthalmol, 253, 1053, 10.1007/s00417-015-2952-z Igic, 1977, Angiotensin I converting enzyme activity in the choroid plexus and in the retinal, 23 Kramkowski, 2006, The physiological significance of the alternative pathways of angiotensin II production, J Physiol Pharmacol, 57, 529 Santos, 2003, Angiotensin (1–7) is an endogenous ligand for the G-protein-coupled receptor Mas, Proc Natl Acad Sci USA, 8, 8258, 10.1073/pnas.1432869100 Kostenis, 2005, G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type I receptor, Circulation, 111, 1806, 10.1161/01.CIR.0000160867.23556.7D Barro-Soria, 2012, Angiotensin-2-mediated Ca2+ signaling in the retinal pigment epithelium: role of angiotensin-receptor-associated-protein and TRPV2 channel, PLoS One, 7, e49624, 10.1371/journal.pone.0049624 Fellner, 2005, Angiotensin II Ca2+signaling in rat afferent arterioles: stimulation of cyclic ADP ribose and IP3 pathways, Am J Physiol Ren Physiol, 288, F785, 10.1152/ajprenal.00372.2004 Boehm, 2007, The eyes in diabetes and diabetes through the eyes, Diabetes Res Clin Prac, 78S, S51, 10.1016/j.diabres.2007.09.023 Tarr, 2013, Pathophysiology of diabetic retinopathy, ISRN Ophthalmol, 34, 35 Funastu, 2003, Pathogenesis of diabetic retinopathy and the renin angiotensin system, Ophthalmic Physiol Opt, 23, 495, 10.1046/j.1475-1313.2003.00134.x Gilbert, 2000, Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes, Diabetologia, 43, 1360, 10.1007/s001250051539 Moravski, 2000, Retinal neovascularization is prevented by blockade of the renin-angiotensin system, Hypertension, 36, 1099, 10.1161/01.HYP.36.6.1099 Nagisa, 2001, The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats, Diabetologia, 44, 883, 10.1007/s001250100556 Sjolie, 2002, The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy, J Hum Hypertens, 16, S42, 10.1038/sj.jhh.1001438 Kurihara, 2008, Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina, Diabetes, 57, 2191, 10.2337/db07-1281 Pons, 2011, Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium, Am J Pathol, 178, 2665, 10.1016/j.ajpath.2011.02.006 Nagai, 2007, Suppression of diabetes induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway, Invest Ophthalmol Vis Sci, 48, 4342, 10.1167/iovs.06-1473 Wilkinson-Berka, 2009, (Pro)renin receptor: a treatment target for diabetic retinopathy?, Diabetes, 58, 1485, 10.2337/db09-0604 Ola, 2013, Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats, Neurochem Res, 38, 1572, 10.1007/s11064-013-1058-4 Miller, 2010, Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function, Diabetes, 59, 3208, 10.2337/db10-0552 Wilkinson-Berka, 2006, Angiotensin and diabetic retinopathy, Int J Biochem Cell Biol, 38, 752, 10.1016/j.biocel.2005.08.002 Wilkinson-Berka, 2008, Prorenin and the (pro)renin receptor in ocular pathology, Am J Pathol, 173, 1591, 10.2353/ajpath.2008.080757 Ichihara, 2004, Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin, J Clin Invest, 114, 1128, 10.1172/JCI21398 Nguyen, 2002, Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin, J Clin Invest, 109, 1417, 10.1172/JCI0214276 Huang, 2007, Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells, Kidney Int, 72, 45, 10.1038/sj.ki.5002243 Kaneshiro, 2007, Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats, J Am Soc Nephrol, 18, 1789, 10.1681/ASN.2006091062 Satofuka, 2007, Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization, Invest Ophthalmol Vis Sci, 48, 422, 10.1167/iovs.06-0534 Vision 2020: The Right to Sight. Global Initiative for the Elimination of Avoidable Blindness: Action Plan 2006–2011. World Health Organization. http://www.who.int/blindness/Vision2020_report.pdf. Hogeboom, 2002, Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy, Diabetologia, 45, 203, 10.1007/s00125-001-0747-8 Zheng, 2009, Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway, Diabetes, 58, 954, 10.2337/db07-1524 Sugiyama, 2007, Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes, Exp Eye Res, 85, 406, 10.1016/j.exer.2007.06.008 White, 2015, Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model, J Renin Angiotensin Aldosterone Syst, 16, 1193, 10.1177/1470320314566018 Haque, 2015, MicroRNA-152 represses VEGF and TGFβ1 expressions through post-transcriptional inhibition of (Pro)renin receptor in human retinal endothelial cells, Mol Vis, 21, 224 Kanda, 2013, The vitreous renin–angiotensin system is mediated by soluble (pro)renin receptor in diabetic retinopathy: a new implication of the receptor-associated prorenin system, Taiwan J Ophthalmol, 3, 51, 10.1016/j.tjo.2013.04.004 Kanda, 2012, (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy, Diabetologia, 55, 3104, 10.1007/s00125-012-2702-2 Satofuka, 2009, (Pro)renin receptor–mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation, Diabetes, 58, 1625, 10.2337/db08-0254 Foureaux, 2015, Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina, Braz J Med Bio Res, 48, 1109, 10.1590/1414-431X20154583 Cullinane, 2002, Renin-angiotensin system expression and secretory function in cultured human ciliary body non-pigmented epithelium, Br J Ophthalmol, 86, 676, 10.1136/bjo.86.6.676 Shen, 2001, Effects of angiotensin II on the 3H-TdR incorporation and synthesis of collagen in cultured bovine trabecular meshwork cells (article in Chinese), Yan Ke Xue Bao, 17, 209 Inoue, 2001, The effect of angiotensin II on uveoscleral outflow in rabbits, Curr Eye Res, 23, 139, 10.1076/ceyr.23.2.139.5470 Mehta, 2010, Oculohypotensive effect of perindopril in acute and chronic models of glaucoma in rabbits, Can J Physiol Pharmacol, 88, 595, 10.1139/Y10-026 Shah, 2000, Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma, J Cardiovasc Pharm, 36, 169, 10.1097/00005344-200008000-00005 Costagliola, 2000, Effect of oral losartan potassium on intraocular pressure in normotensive and glaucomatous human subjects, Exp Eye Res, 71, 167, 10.1006/exer.2000.0866 Wang, 2005, Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes, Exp Eye Res, 80, 629, 10.1016/j.exer.2004.11.012 Lotti, 1990, Prostaglandins mediate the ocular hypotensive action of the angiotensin converting enzyme inhibitor MK-422 (enalaprilat) in African green monkeys, J Ocul Pharmacol, 6, 1, 10.1089/jop.1990.6.1 Reitsamer, 2003, Relationship between ciliary body blood flow and aqueous production in rabbits, Invest Ophthalmol Vis Sci, 44, 3967, 10.1167/iovs.03-0088 Sharif, 2015, Novel potential treatment modalities for ocular hypertension: focus on angiotensin and bradykinin system axes, J Ocul Pharmacol Ther, 31, 131, 10.1089/jop.2014.0114 Nagai, 2007, Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin, Invest Ophthalmol Vis Sci, 48, 2321, 10.1167/iovs.06-1296 Ishida, 2009, Lifestyle-related diseases and anti-aging ophthalmology: suppression of retinal and choroidal pathologies by inhibiting renin-angiotensin system and inflammation, Nihon Ganka Gakkai Zasshi, 113, 403 Satofuka, 2008, (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin angiotensin system, Am J Pathol, 173, 1911, 10.2353/ajpath.2008.080457 Nagai, 2006, Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization, Arterioscler Thromb Vasc Bio, 26, 2252, 10.1161/01.ATV.0000240050.15321.fe Nagai, 2005, Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor, Invest Ophthalmol Vis Sci, 46, 2925, 10.1167/iovs.04-1476 Okunuki, 2009, Suppression of experimental autoimmune uveitis by angiotensin II type 1receptor blocker telmisartan, Invest Ophthalmol Vis Sci, 50, 2255, 10.1167/iovs.08-2649 Kurihara, 2006, Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation, Invest Ophthalmol Vis Sci, 47, 5545, 10.1167/iovs.06-0478 Miyazaki, 2008, Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats, Graefe's Arch Clin Exp Ophthalmol, 246, 747, 10.1007/s00417-007-0730-2 Nagai, 2005, Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor, Invest Ophthalmol Vis Sci, 46, 1078, 10.1167/iovs.04-1101 Qiu, 2014, Angiotensin-converting enzyme 2 (ACE2) activator dize ameliorates endotoxin-induced uveitis in mice, Invest Ophthalmol Vis Sci, 55, 3809, 10.1167/iovs.14-13883 Khan, 2016, Hypertension potentiates cataractogenesis in rat eye through modulation of oxidative stress and electrolyte homeostasis, J Curr Ophthalmol, 28, 123 Jablecka, 2009, Influence of selected angiotensin-converting enzyme inhibitors on alloxan-induced diabetic cataract in rabbits, Med Sci Monit, 15, BR334 Langade, 2006, In vitro prevention by ACE inhibitors of cataract induced by glucose, Indian J Pharmacol, 38, 107, 10.4103/0253-7613.24615 Harindhanavudhi, 2011, Benefits of renin-angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control, Diabetes Care, 34, 1838, 10.2337/dc11-0476 Sjolie, 2011, Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review, Int J Clin Pract, 65, 148, 10.1111/j.1742-1241.2010.02552.x Otani, 1998, Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells, Circ Res, 82, 619, 10.1161/01.RES.82.5.619 Otani, 2000, Angiotensin II-stimulated potentiates vascular endothelial growth factor expression in bovine retinal pericytes, Invest Ophthalmol Vis Sci, 41, 1192 Chaturvedi, 2000, Modulation of renin-angiotensin system and retinopathy, Heart, 84, i29, 10.1136/heart.84.suppl_1.i29 Clermont, 2006, Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond, J Hypertens, 24, S73, 10.1097/01.hjh.0000220410.69116.f8 Mauer, 2009, Renal and retinal effects of enalapril and losartan in type 1 diabetes, N Engl J Med, 361, 40, 10.1056/NEJMoa0808400 Wilkinson-Berka, 2007, Valsartan but not atenolol improves vascular pathology in diabetic ren-2 rat retina, Am J Hypertens, 20, 423, 10.1016/j.amjhyper.2006.09.018 Fernandez, 1985, Neovascularization produced by angiotensin II, J Lab Clin Med, 105, 141 Aiello, 1997, Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor, Diabetes, 46, 1473, 10.2337/diab.46.9.1473 Funatsu, 2002, Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders, Am J Ophthalmol, 133, 537, 10.1016/S0002-9394(02)01323-5 Funatsu, 2002, Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy, Bri J Ophthalmol, 86, 311, 10.1136/bjo.86.3.311 Schiffman, 1992, Prorenin and renin levels in the vitreous of human eyes with and without proliferative diabetic retinopathy, Invest Ophthalmol Vis Sci, 33, 1362 Pradhan, 2002, Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive type 2 diabetic patients a pilot study, J Diabetes Complications, 16, 377, 10.1016/S1056-8727(02)00188-5 Chaturvedi, 2008, Direct programme study group. Effect of candesartan on prevention (Direct Prevent 1) and progression (Direct Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials, Lancet, 372, 1394, 10.1016/S0140-6736(08)61412-9 Gilbert, 1998, Vascular endothelial growth factor and its receptors in control and diabetic rat eyes, Lab Invest, 78, 1017 Vaajanen, 2011, Local ocular renin–angiotensin system – a target for glaucoma therapy?, Basic Clin Pharmacol Toxicol, 9, 217, 10.1111/j.1742-7843.2011.00729.x Bathija, 1998, Changing definition of glaucoma, J Glaucoma, 7, 165, 10.1097/00061198-199806000-00004 Bonomi, 2000, Vascular risk factors for primary open angle glaucoma: the Enga-Neumarkt study, Ophthalmology, 107, 1287, 10.1016/S0161-6420(00)00138-X Drance, 2001, Collaborative normal-tension glaucoma study group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma, Am J Ophthalmol, 131, 699, 10.1016/S0002-9394(01)00964-3 Flammer, 1999, Vascular dysregulation: a principal risk factor for glaucomatous damage?, J Glaucoma, 8, 212, 10.1097/00061198-199906000-00012 Quigley, 2015, Losartan treatment protects retinal ganglion cells and alters scleral remodeling in experimental glaucoma, PLoS One, 10, e0141137, 10.1371/journal.pone.0141137 Yang, 2009, Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma, Invest Ophthalmol Vis Sci, 50, 5800, 10.1167/iovs.09-3678 Espinosa-Heidmann, 2003, Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization, Invest Ophthalmol Vis Sci, 44, 3586, 10.1167/iovs.03-0038 Sakurai, 2003, Macrophage depletion inhibits experimental choroidal neovascularization, Invest Ophthalmol Vis Sci, 44, 3578, 10.1167/iovs.03-0097 Tsutsumi, 2003, The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization, J Leukoc Biol, 74, 25, 10.1189/jlb.0902436 Gragoudas, 2004, Pegaptanib for neovascular age-related macular degeneration, New Engl J Med, 351, 2805, 10.1056/NEJMoa042760 Rosenfeld, 2006, Ranibizumab for neovascular age-related macular degeneration, New Engl J Med, 355, 1419, 10.1056/NEJMoa054481 Praddaude, 2009, Angiotensin II induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium, Exp Eye Res, 89, 109, 10.1016/j.exer.2009.02.020 Striker, 2008, Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II, Am J Physiol Cell Physiol, 295, C1633, 10.1152/ajpcell.00092.2008 Nabah, 2004, Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines, Circulation, 110, 3581, 10.1161/01.CIR.0000148824.93600.F3 Alcazar, 2009, (Pro)renin receptor is expressed in human retinal pigment epithelium and participates in extracellular matrix remodeling, Exp Eye Res, 89, 638, 10.1016/j.exer.2009.06.014 Nahmod, 2003, Control of dendritic cell differentiation by angiotensin II, FASEB J, 17, 491, 10.1096/fj.02-0755fje Pastore, 1999, Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo, Circulation, 100, 1646, 10.1161/01.CIR.100.15.1646 Gupta, 2009, Advances in pharmacological strategies for the prevention of cataract development, Indian J Ophthalmol, 57, 175, 10.4103/0301-4738.49390 Sabanayagam, 2011, Metabolic syndrome components and age-related cataract: the Singapore Malay eye study, Invest Ophthalmol Vis Sci, 52, 2397, 10.1167/iovs.10-6373 Phipps, 2007, Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol, Invest Ophthalmol Vis Sci, 48, 927, 10.1167/iovs.06-0892 Strain, 2002, The renin-angiotensin-aldosterone system and the eye in diabetes, J Renin Angiotensin Aldosterone Syst, 3, 243, 10.3317/jraas.2002.045